238 related articles for article (PubMed ID: 17564969)
1. RNA interference-mediated suppression and replacement of human rhodopsin in vivo.
O'Reilly M; Palfi A; Chadderton N; Millington-Ward S; Ader M; Cronin T; Tuohy T; Auricchio A; Hildinger M; Tivnan A; McNally N; Humphries MM; Kiang AS; Humphries P; Kenna PF; Farrar GJ
Am J Hum Genet; 2007 Jul; 81(1):127-35. PubMed ID: 17564969
[TBL] [Abstract][Full Text] [Related]
2. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ
Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651
[TBL] [Abstract][Full Text] [Related]
3. Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy.
Chadderton N; Millington-Ward S; Palfi A; O'Reilly M; Tuohy G; Humphries MM; Li T; Humphries P; Kenna PF; Farrar GJ
Mol Ther; 2009 Apr; 17(4):593-9. PubMed ID: 19174761
[TBL] [Abstract][Full Text] [Related]
4. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa.
Millington-Ward S; Chadderton N; O'Reilly M; Palfi A; Goldmann T; Kilty C; Humphries M; Wolfrum U; Bennett J; Humphries P; Kenna PF; Farrar GJ
Mol Ther; 2011 Apr; 19(4):642-9. PubMed ID: 21224835
[TBL] [Abstract][Full Text] [Related]
5. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.
Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE
Nat Commun; 2021 Aug; 12(1):4934. PubMed ID: 34400638
[TBL] [Abstract][Full Text] [Related]
6. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
Mitra RN; Zheng M; Weiss ER; Han Z
Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
[TBL] [Abstract][Full Text] [Related]
7. Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice.
Mao H; Gorbatyuk MS; Rossmiller B; Hauswirth WW; Lewin AS
Hum Gene Ther; 2012 Apr; 23(4):356-66. PubMed ID: 22289036
[TBL] [Abstract][Full Text] [Related]
8. Cellular expression and siRNA-mediated interference of rhodopsin cis-acting splicing mutants associated with autosomal dominant retinitis pigmentosa.
Hernan I; Gamundi MJ; Planas E; Borràs E; Maseras M; Carballo M
Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3723-9. PubMed ID: 21357407
[TBL] [Abstract][Full Text] [Related]
9. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
[TBL] [Abstract][Full Text] [Related]
10. Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference.
Cashman SM; Binkley EA; Kumar-Singh R
Gene Ther; 2005 Aug; 12(15):1223-8. PubMed ID: 15877050
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller B; Mao H; Lewin AS
Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10).
Tam LC; Kiang AS; Kennan A; Kenna PF; Chadderton N; Ader M; Palfi A; Aherne A; Ayuso C; Campbell M; Reynolds A; McKee A; Humphries MM; Farrar GJ; Humphries P
Hum Mol Genet; 2008 Jul; 17(14):2084-100. PubMed ID: 18385099
[TBL] [Abstract][Full Text] [Related]
13. Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
Gorbatyuk M; Justilien V; Liu J; Hauswirth WW; Lewin AS
Vision Res; 2007 Apr; 47(9):1202-8. PubMed ID: 17292939
[TBL] [Abstract][Full Text] [Related]
14. Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.
Cideciyan AV; Sudharsan R; Dufour VL; Massengill MT; Iwabe S; Swider M; Lisi B; Sumaroka A; Marinho LF; Appelbaum T; Rossmiller B; Hauswirth WW; Jacobson SG; Lewin AS; Aguirre GD; Beltran WA
Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8547-E8556. PubMed ID: 30127005
[TBL] [Abstract][Full Text] [Related]
15. Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa.
Mussolino C; Sanges D; Marrocco E; Bonetti C; Di Vicino U; Marigo V; Auricchio A; Meroni G; Surace EM
EMBO Mol Med; 2011 Mar; 3(3):118-28. PubMed ID: 21268285
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus-mediated rhodopsin replacement provides therapeutic benefit in mice with a targeted disruption of the rhodopsin gene.
Palfi A; Millington-Ward S; Chadderton N; O'Reilly M; Goldmann T; Humphries MM; Li T; Wolfrum U; Humphries P; Kenna PF; Farrar GJ
Hum Gene Ther; 2010 Mar; 21(3):311-23. PubMed ID: 19824806
[TBL] [Abstract][Full Text] [Related]
17. Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme.
Gorbatyuk M; Justilien V; Liu J; Hauswirth WW; Lewin AS
Exp Eye Res; 2007 Jan; 84(1):44-52. PubMed ID: 17083931
[TBL] [Abstract][Full Text] [Related]
18. Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa.
Greenwald DL; Cashman SM; Kumar-Singh R
Gene Ther; 2013 Apr; 20(4):425-34. PubMed ID: 22809998
[TBL] [Abstract][Full Text] [Related]
19. Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery.
Giannelli SG; Luoni M; Castoldi V; Massimino L; Cabassi T; Angeloni D; Demontis GC; Leocani L; Andreazzoli M; Broccoli V
Hum Mol Genet; 2018 Mar; 27(5):761-779. PubMed ID: 29281027
[TBL] [Abstract][Full Text] [Related]
20. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
